Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Low vitamin D levels are linked to severe and active alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

New therapies for alopecia areata show potential but need more research.

Yellow dots are common in severe alopecia areata.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Infliximab may cause hair loss in Crohn's disease patients.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Stress can trigger or worsen alopecia areata.